| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Edward K. Russell | SVP, Business Development | $457,271 | 16 Jan 2022 | ||
| Charles P. Slacik | Director | $378,574 | 25 Jan 2022 | ||
| Randall J. Steward | Chief Financial Officer | $359,541 | 03 Feb 2022 | ||
| Kathy Ordonez | Director | $45,554 | 18 May 2021 | ||
| Edward L. Michael | Director | 27 May 2022 | |||
| Douglas C. Bryant | President & CEO, Director | 27 May 2022 | |||
| WIDDER KENNETH J | Director | 27 May 2022 | |||
| Kenneth F. Buechler | Director | 27 May 2022 | |||
| Ann D. Rhoads | Director | 27 May 2022 | |||
| Michelle A. Hodges | SVP, General Counsel | 27 May 2022 | |||
| Robert J. Bujarski | Chief Operating Officer | 27 May 2022 | |||
| Joseph D. Wilkins Jr. | Director | 27 May 2022 | |||
| Ph.D. Mary Lake Polan | Director | 27 May 2022 | |||
| Tamara A. Ranalli | SVP, Molecular Bus. Unit | 27 May 2022 | |||
| William J. Ferenczy | SVP, Cardio/Metabolic Unit | 27 May 2022 | |||
| Werner Kroll | Svp, R&D | 27 May 2022 | |||
| Matthew W. Strobeck | Director | 27 May 2022 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||